4.5 Article

PGE1 and E3 show lower efficacies than E2 to β- catenin-mediated activity as biased ligands of EP4 prostanoid receptors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

The Roles of EP4 Prostanoid Receptors in Cancer Malignancy Signaling

Hiromichi Fujino

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)

Review Oncology

Prostaglandin E3 metabolism and cancer

Peiying Yang et al.

CANCER LETTERS (2014)

Review Pharmacology & Pharmacy

E-type prostanoid receptor 4 (EP4) in disease and therapy

Viktoria Konya et al.

PHARMACOLOGY & THERAPEUTICS (2013)

Review Pharmacology & Pharmacy

The Prostanoid EP4 Receptor and Its Signaling Pathway

Utako Yokoyama et al.

PHARMACOLOGICAL REVIEWS (2013)

Review Biochemistry & Molecular Biology

The role of cyclooxygenase-2 and prostaglandins in colon cancer

Annie L. Eisinger et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)

Article Multidisciplinary Sciences

Melanoma growth is reduced in fat-1 transgenic mice: Impact of omega-6/omega-3 essential fatty acids

Shuhua Xia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Pharmacology & Pharmacy

Cancer prevention: A new era beyond cyclooxygenase-2

B Rigas et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)

Article Biochemistry & Molecular Biology

Formation and anti proliferative effect of prostaglandin E3 from eicosapentaenoic acid in human lung cancer cells

PY Yang et al.

JOURNAL OF LIPID RESEARCH (2004)